Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 USD | -0.34% | +3.13% | -16.34% |
01/04 | Dynavax Technologies Corporation Announces Chief Financial Officer Changes | CI |
23/02 | Dynavax Technologies Reports Breakeven Q4 Earnings, Lower Revenue | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.34% | 1.54B | |
+8.90% | 105B | |
-1.13% | 104B | |
+5.79% | 22.94B | |
-12.36% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.04% | 16.96B | |
+7.83% | 14.16B | |
+38.71% | 12.63B |
- Stock Market
- Equities
- DVAX Stock
- News Dynavax Technologies Corporation
- Biological E. Starts Phase I/II Clinical Trial of its COVID-19 Vaccine in India